|
 |
SORIATANEThis page contains recent news articles, when available, and an overview of SORIATANE but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.If those medications don't provide enough relief, oral retinoid medications -- isotretinoin (Accutane) or acitretin (Soriatane), for example -- may ... Hartford Courant Perrigo Announces Dismissal Of Duac Patent Litigation - Update - Oct 19, 2009 The deal combined GSK's prescription dermatology products with Stiefel's portfolio, which included brands such as Duac, Olux and Soriatane. ... RTT News Connetics Files Citizen Petition for Soriatane With the FDA; Emphasize... - Apr 3, 2006 Connetics Corporation (NASDAQ:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, today announced the filing of ... Genetic Engineering News - Genetic Engineering News (press release) Connetics Corporation Announces 2006 Financial Guidance Conference … - Dec 19, 2005 Next, we've determined that it is prudent to take actions and provide guidance for '07 that assume the entry of a generic Soriatane. As you may know, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Soriatane.(Drug overview) - Jan 22, 2007 Soriatane is prescribed for several types of severe psoriasis, a chronic skin condition that causes inflamed red patches with silvery scales. ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Low-Dose Regimens of Soriatane(R) (Acitretin) Effective in the... - Mar 3, 2006 PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, ... $4.95 - Business Wire - ECNext Favorable Soriatane Cost-Effectiveness Analysis is Published in... - May 11, 2005 PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, ... $4.95 - Business Wire - ECNext Soriatane[R] (acitretin) effective in treating plaque-type psoriasis.(... - Aug 1, 2006 Soriatane[R] (acitretin) effective in treating plaque-type psoriasis.(New Products) ... find Dermatology Nursing articles. Connetics Corporation announced ... Pay-Per-View - Dermatology Nursing - HighBeam Research Event Brief of Q4 2004 Connetics Earnings Conference Call - Part 1. - Jan 25, 2005 ...s existing product prescriptions for Luxiq, OLUX, and Soriatane were encouraging. ... Soriatane rolled up at $53.3m. 4. Evoclin, launched in the last couple ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Generic Drugs; Connetics files Citizen Petition for Soriatane with... - May 3, 2006 2006 MAY 3 - (NewsRx.com) -- Connetics Corporation (CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Generic Drugs; Connetics files Citizen Petition for Soriatane with... - May 4, 2006 2006 MAY 4 - (NewsRx.com) -- Connetics Corporation (CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones New psoriasis drugs give hope . - Nov 9, 2005 Soriatane is also taken by mouth. It's related to a powerful acne drug and cannot be taken before or during pregnancy. There are new treatments called ... Eugene Register-Guard - Google News Archive … Revenues Increase 19 Percent; OLUX, Soriatane and Evoclin Achieve... - Aug 2, 2005 Second quarter sales of Soriatane were $18.3 million. ... This distributor relationship has been in place for Soriatane, OLUX and Luxiq(R) since 2004. ... $4.95 - Business Wire - ECNext Soriatane[R] (acitretin) effective in treating plaque-type psoriasis.(... - Aug 1, 2006 Connetics Corporation announced results of a Phase IV clinical study evaluating the long-term efficacy of a lower dosage of Soriatane[R] (acitretin) which ... $4.95 - Dermatology Nursing - ECNext Q1 2006 Connetics Earnings Conference Call - Part 2. - May 3, 2006 Soriatane, you mentioned that it's coming in a little bit below expectations. ... The Soriatane trends are based on the United States trends, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Connetics Announces First Quarter Results with Product Sales up 79 … - Apr 26, 2005 Soriatane sales were $17.6 million during the quarter and Evoclin sales were $3.1 million. Royalty and contract revenues for the first quarter of 2005 were ... $4.95 - Business Wire - ECNext æ–°å?Žç¾Žé€šæ¶ˆæ?¯ï¼šStiefelLaboratories任命首任首å¸ç§‘å¦å®˜ - Apr 8, 2008 ...å’ŒOlux-Eâ„¢(丙酸氯å€?ä»–ç´¢)Foam，0.05%ï¼›å?¯åœ¨Soriatane® CK CONVENIENCE KIT ä¸èŽ·å¾— çš„Soriatane®(阿曲汀)Capsulesï¼›Verdesoâ„¢(地索奈德)Foam，0.05%；包装在Brevoxyl® ... ä¸é‡‘在线 Connetics psoriasis treatment shows low-dose efficacy - Mar 6, 2006 Connetics Corporation has announced that results of a phase IV clinical study evaluating the long-term efficacy of a lower dosage of Soriatane show that ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Connetics Announces Highlights of Discovery Day 2005; Live Webcast … - Oct 3, 2005 ...--Soriatane Update: Connetics recently extended its finished goods supply ... In addition, the Company does not foresee generic Soriatane entering the ... $4.95 - Business Wire - ECNext Company Profile Report - Dec 16, 2006 Connetics acquired the exclusive United States rights to Soriatane from Hoffmann-La ... Soriatane is an approved oral therapy for the treatment of severe ... $50.00 - Revere Reports - Revere Stiefel acquisition marries technology, marketing: foam vehicle... - Mar 1, 2007 Stiefel also is acquiring Connetics' Soriatane (acitretin), he notes. While its patent protection expires relatively soon, "Because of the pregnancy issue ... $4.95 - Dermatology Times - ECNext Drug/Medical Device - Dec 16, 2006 Connetics acquired the exclusive United States rights to Soriatane from Hoffmann-La ... Soriatane is an approved oral therapy for the treatment of severe ... $70.00 - Revere Reports - Revere TOP TALENT AND RAPID R&D PUT CONNETICS ON FAST TRACK - - Apr 11, 2005 Connetics has four drugs on the market: Luxiq for scalp ailments, Evoclin for acne, OLUX for moderate psoriasis and Soriatane for severe psoriasis. ... $2.95 - San Jose Mercury News - NewsBank Competitors by Product Report - Dec 16, 2006 Connetics acquired the exclusive United States rights to Soriatane from Hoffmann-La ... Soriatane is an approved oral therapy for the treatment of severe ... $75.00 - Revere Reports - Revere Finance; Dermatology company reports Q4 net income of $6.4M; product ... - Feb 22, 2005 We also marked the success of 2004 with the acquisition of Soriatane. "Through our promotional efforts Soriatane was a significant financial contributor in ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Connetics Presents 11 Scientific Posters at American Academy of … - Feb 17, 2005 Another psoriasis poster will feature Soriatane(R), demonstrating low-dose therapy ... Soriatane Low Dose 8. Soriatane in Hyperkeratotic Hand Disease 9. ... $4.95 - Business Wire - ECNext ë°”ë¥¸ì–¸ë¡ ë¹ ë¥¸ë‰´ìŠ¤ ì?¸í„°ë„· 연합뉴스 - May 7, 2008 0.05% ; Soriatane(R) CK CONVENIENCE KITì—? ì?´ìš©í• 수 있는 Soriatane(R) (acitretin) 캡ìŠ? ; Verdeso(R) (desonide) Foam, 0.05%; Brevoxyl(R)-4 í?¬ë¦¬ë¯¸ ... 연합뉴스 Finance; Dermatology company reports Q4 net income of $6.4M; product ... - Feb 25, 2005 We also marked the success of 2004 with the acquisition of Soriatane. "Through our promotional efforts Soriatane was a significant financial contributor in ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Stiefel Laboratories Announces Expiration of Hart-Scott-Rodino... - Jul 29, 2008 0.05% also available in the Olux(R) / Olux-E(R) COMPLETE PACK; Soriatane(R) (acitretin) Capsules available in the Soriatane(R) CK CONVENIENCE KIT; ... Lifescience-online Event Brief of Q1 2006 Connetics Earnings Conference Call - Part 1. - May 3, 2006 The prescription trends for OLUX and Soriatane are below forecast levels. 2. ... CNCT has a lot of new marketing initiatives for Soriatane and a great sales ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Q3 2005 Connetics Earnings Conference Call - Part 2. - Nov 1, 2005 Is it incorrect for me to - if I was to subtract the $7 million Soriatane revenue adjustment out that that would also equate to the $0.16 having to come out ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com St. John's Wort.(Drug overview) - Feb 1, 2007 Acitretin (Soriatane(R)) * Aminolevulinic acid (Levulan Kerastick(R)) ... Product Information: Soriatane(R), acitretin. Roche Laboratores, Inc, Nutley, NJ; ... Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com Stiefel Laboratories 任命首任首å¸ç§‘å¸å®˜ - Apr 8, 2008 ...æ°¯å€?他索）Foam，0.05% å’ŒOlux-E(TM)（丙酸氯å€?他索）Foam，0.05%ï¹”å?¯åœ¨Soriatane(R) CK CONVENIENCE KIT ä¸ç?²å¾—çš„Soriatane(R)（阿曲汀）Capsulesï¹”Verdeso(TM)（ ... 財è?¯ç¶² Connetics Presents Eight Scientific Posters at the 64th Annual... - Mar 2, 2006 Connetics will sponsor a poster featuring Soriatane(R) (acitretin) that highlights the safety and efficacy of low-dose acitretin in the treatment of ... Free with registration - Business Wire - AccessMyLibrary.com Stiefel Laboratories, Inc. Kuasai ABR Invent dan ABR Development - May 7, 2008 Busa, 0.12 persen; MimyX(R) Krim; Olux(R) (klobetasol propionate) Busa, 0.05 persen dan Olux-E(TM) KEMASAN LENGKAP; Soriatane(R) (acitretin) Kapsul tersedia ... ANTARA Stiefel Laboratories Angkat Kepala Ilmiah Utama - Apr 8, 2008 Busa, 0.12 persen; MimyX(R) Krim; Olux(R) (klobetasol propionate) Busa, 0.05 persen dan Olux-E(TM) KEMASAN LENGKAP; Soriatane(R) (acitretin) Kapsul tersedia ... ANTARA Stiefel Laboratories 收購ABR Invent å’ŒABR Development - May 7, 2008 ...æ°¯å€?他索）Foam，0.05% å’ŒOlux-E(TM)（丙酸氯å€?他索）Foam，0.05%ï¹”å?¯åœ¨Soriatane(R) CK CONVENIENCE KIT ä¸ç?²å¾—çš„Soriatane(R)（阿曲汀）Capsulesï¹”Verdeso(TM)（ ... 財è?¯ç¶² Too Hard To Take; A Strict New Acne Drug Program May Prevent Birth … - Sep 5, 2006 ...the psoriasis drugs Soriatane and Tegison (which the FDA labels Category X -- never safe during pregnancy - - as it does Accutane); and over-the-counter ... Pay-Per-View - Washington Post - ProQuest Archiver Press Release: Stiefel Laboratories, Inc. Successfully Completes... - Aug 5, 2008 0.05% also available in the Olux(R) / Olux-E(R) COMPLETE PACK; Soriatane(R) (acitretin) Capsules available in the Soriatane(R) CK CONVENIENCE KIT; ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Stiefel Laboratories, Inc. Commences Tender Offer to … - Jul 8, 2008 0.05% also available in the Olux(R) / Olux-E(R) COMPLETE PACK; Soriatane(R) (acitretin) Capsules available in the Soriatane(R) CK CONVENIENCE KIT; ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Covance Reports 1Q07 Earnings of $0.60 Per Share. - … - Apr 30, 2007 Article: Connetics to Acquire U.S. Soriatane (Acitretin) Product Rights . ... "Soriatane, an oral treatment approved by the FDA in 1997 with proven benefit ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Stiefel Laboratories, Inc. Announces Expiration of... - Jul 29, 2008 0.05% also available in the Olux(R) / Olux-E(R) COMPLETE PACK; Soriatane(R) (acitretin) Capsules available in the Soriatane(R) CK CONVENIENCE KIT; ... Pay-Per-View - PR Newswire - HighBeam Research Born Too Soon - Her Body: The Puzzle of Premature Birth - Mar 5, 2007 ...as are ACE Inhibitors (used to treat high blood pressure) and two drugs for psoriasis, Tegison (etretinate) and Soriatane (acitretin). ... $2.95 - Newsweek - NewsBank Connetics Reports Second Quarter Financial Results. - Aug 14, 2006 Second quarter 2006 revenues include Soriatane(R) sales of $16.3 million, OLUX(R) sales of $12.2 million, Evoclin(R) sales of $9.3 million and Luxiq(R) ... $4.95 - Business Wire - ECNext Connetics Reports Third Quarter Financial Results - Nov 8, 2006 Third quarter 2006 product revenues include Soriatane® sales of $10.4 million, OLUX® sales of $4.3 million, Evoclin® sales of $2.3 million and LuxÃq® sales ... RedOrbit Event Brief of Q4 2005 Connetics Earnings Conference Call - Final. - Jan 31, 2006 Soriatane had a 2% YoverY growth rate. 4. RX growth engine in 2005 was Evoclin, ... Soriatane posted $13.6m. 3. Evoclin posted $6.9m. 4. Luxiq was $5.6m. 5. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Stiefel Laboratories nomme son premier directeur scientifique - Apr 8, 2008 Olux(R) / Olux-E(TM) ; les capsules Soriatane(R) (acitrétine) disponibles dans le KIT COVENIENCE Soriatane(R) ; la mousse Verdeso(TM) (désonide), ... Caducée.net COMUNICADO: Stiefel Laboratories elige a su primer director cientÃfico - Apr 8, 2008 0,05% también disponible en el PAQUETE COMPLETO Olux(R) / Olux-E(TM); Soriatane(R) (acitretina) Cápsulas disponible en el KIT Soriatane(R) CK; ... elEconomista.es Business & Finance; Dermatology company reports fourth-quarter … - Mar 7, 2006 Fourth-quarter 2005 product revenues included OLUX sales of $14.7 million, Soriatane sales of $13.6 million, Evoclin sales of $6.9 million, and Luxiq sales ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Business & Finance; Connetics reports preliminary results for first... - May 31, 2006 Total revenues for the first quarter of 2006 were $47.7 million, including Soriatane sales of $19.0 million, OLUX sales of $14.1 million, Evoclin sales of ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones St. John's Wort.(Health Aspects) - May 1, 2006 Acitretin (Soriatane(R)) * Aminolevulinic acid (Levulan Kerastick(R)) ... Product Information: Soriatane(R), acitretin. Roche Laboratores, Inc, Nutley, NJ; ... Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com Merci de me répondre et bon courage à tous - Apr 4, 2008 Soriatane très contraignant mais efficace sur la durée. J'habite le Québec et ma fille de 2 ans est atteinte d'érithrodermie ichthyosiforme congénitale ... E-Santé.fr Stiefel Laboratories Will Enter Into Private Equity Minority Investmen... - Aug 9, 2007 0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; ... Free with registration - PR Newswire - AccessMyLibrary.com How Common Drugs Compare on Safety in Pregnancy - Oct 11, 2005 Includes the acne drug Accutane and psoriasis medications Tegison and Soriatane. Register to Help One way drug manufacturers learn about the safety of ... Washington Post DUSA Expands Global Sales With Launch of Levulan ® Kerastick ® in … - Oct 1, 2007 0.12%; MimyX ® ; Olux TM (clobetasol propionate) Foam, 0.05%; Olux-E TM (clobetasol propionate) Foam, 0.05%; Soriatane ® (acitretin) capsules; ... marketwire.com JE SUIS ATTEINTE MOI AUSSI D ICHTYOSE VULGAIRE? G TOUT … - Apr 3, 2006 ...salut je m'appelle camille, j'ai 21 ans et j'ai une ichtyose type bébé collodion, ma soeur de 17 ans est atteinte de la même chose, je prends du soriatane ... E-Santé.fr Photo Quiz - April 15, 2007 -- American Family Physician - Apr 15, 2007 Acitretin (Soriatane) is an oral retinoid for the systemic treatment of psoriasis. It is indicated for generalized pustular and erythrodermic disease forms, ... AAFP News Now Press Release: Covance Reports Strong Earnings Growth of 28% to … - Jul 20, 2005 Article: Connetics to Acquire U.S. Soriatane (Acitretin) Product Rights . ... "Soriatane, an oral treatment approved by the FDA in 1997 with proven benefit ... Pay-Per-View - PR Newswire - HighBeam Research FDA Approves Extina(R) for the Treatment of Seborrheic Dermatitis - Jul 17, 2007 0.12%; MimyX(R) Cream; Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; ... RedOrbit Press Release: Select International Sets New Standard for Call Center... - May 23, 2005 Article: Connetics Announces Agreement With Distributor of Soriatane to ... ... Roche to sell Soriatane(R) to a U.S.-based distributor that exports branded ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Covance Reports Earnings Growth of 30% to $0.54/Share … - Jul 24, 2006 Article: Connetics to Acquire U.S. Soriatane (Acitretin) Product Rights . ... "Soriatane, an oral treatment approved by the FDA in 1997 with proven benefit ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Select International Helps Willson Improve US-Canada … - Jun 20, 2005 Article: Connetics Announces Agreement With Distributor of Soriatane to ... ... Roche to sell Soriatane(R) to a U.S.-based distributor that exports branded ... Pay-Per-View - PR Newswire - HighBeam Research Toxicologist Syed Nurul Alam Dies | Article from The Washington Post... - Jun 18, 2005 He was known at the FDA for his expertise in the toxicological effects of retinoids, vitamin A derivatives that include Accutane and Soriatane. ... Pay-Per-View - Washington Post - HighBeam Research How Common Drugs Compare on Safety in Pregnancy | Article from The … - Oct 11, 2005 Includes the acne drug Accutane and psoriasis medications Tegison and Soriatane. Register to Help One way drug manufacturers learn about the safety of ... Pay-Per-View - Washington Post - HighBeam Research Toxicologist Syed Nurul Alam Dies - Jun 18, 2005 He was known at the FDA for his expertise in the toxicological effects of retinoids, vitamin A derivatives that include Accutane and Soriatane. ... Pay-Per-View - Washington Post - ProQuest Archiver Stiefel Laboratories, Inc. Enters into Strategic Collaboration with... - Nov 6, 2007 MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) CK Convenience Kit; ... Free with registration - PR Newswire - AccessMyLibrary.com Options limited for comorbid psoriasis, hepatitis C.(Psoriasis) - Oct 1, 2007 Acitretin (Soriatane). There is no evidence that this drug causes hepatotoxicity, even after 2 years of continuous exposure (J. Am. Acad. Dermatol. ... Free with registration - Skin & Allergy News - AccessMyLibrary.com Acquired kinking of the hair caused by acitretin.(CASE REPORTS)(Case ... - Sep 1, 2007 Acitretin (Soriatane[R] Connetics) is the active free acid metabolite of etretinate, first introduced in the late 1980s for the treatment of psoriasis. ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com DR. PAUL DONOHUE GOOD HEALTH - Nov 9, 2005 Soriatane is also taken by mouth. It's related to a powerful acne drug and cannot be taken before or during pregnancy. There are new treatments called ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Ohio Miscellaneous Reports - JOHNSON v. DEPT. OF REHAB. & CORR., … - Jan 26, 2006 ...which had been previously controlled through a combination of daily doses of Soriatane 25 MG capsules and Hydroxyzine HCL 25 tablets * * *. ... Pay-Per-View - Ohio Miscellaneous Reports - Loislaw PREGNANCY POSES EXTRA RISKS FROM DRUGS - Oct 23, 2005 Includes the acne drug Accutane and psoriasis medications Tegison and Soriatane. One way drug manufacturers learn about the safety of medications is through ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Gauging medicine risks for the pregnant, FDA revises list of safe... - Oct 18, 2005 Includes the acne drug Accutane and psoriasis medications Tegison and Soriatane. One way drug manufacturers learn about the safety of medications is through ... Pay-Per-View - Newsday - ProQuest Archiver March of Dimes Applauds FDA Monitoring Program. - Feb 9, 2006 The organization's comments came in a national policy statement on retinoid drugs such as Accutane and the psoriasis medication Soriatane (acitretin). ... Free with registration - PR Newswire - AccessMyLibrary.com DermTech and Stiefel Laboratories, Inc. Begin Feasibility Study to … - Jan 7, 2008 0.05%) Foam; Olux-E(TM) (clobetasol propionate, 0.05%) Foam; Soriatane(R) (acitretin) CK CONVENIENCE KIT(TM); Verdeso(TM) (desonide, 0.05%) Foam; ... Free with registration - PR Newswire - AccessMyLibrary.com Are common drugs safe during pregnancy? - Nov 14, 2005 Includes the acne drug Accutane and psoriasis medications Tegison and Soriatane. One way drug manufacturers learn about the safety of medications is through ... Pay-Per-View - Wichita Eagle - Factiva, from Dow Jones Connetics Corporation to Merge into Stiefel Laboratories. - Oct 23, 2006 The Company's commercial products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) ... Free with registration - PR Newswire - AccessMyLibrary.com Stiefel Laboratories Moves to Solidify, Enhance Its Leadership... - Apr 23, 2007 0.12%; MimyX(TM) Cream; Olux(R) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; ... $4.95 - PR Newswire - ECNext How to take Tretinoin from Consumer Reports Health. - Jan 6, 2008 ...tell your doctor and pharmacist if you are allergic to tretinoin, other retinoids such as acitretin (Soriatane), etretinate (Tegison), bexarotene, ... consumerreports.org Connetics Announces Expiration of Hart-Scott-Rodino Waiting Period. - Dec 15, 2006 ...q([R]) (betamethasone valerate) Foam, 0.12%; Soriatane([R]) (acitretin) capsules; Evoclin([R]) (clindamycin) Foam, 1%; and Verdeso[TM] (desonide) Foam, ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Receives Notice from Nasdaq Due to Late Filing of Form 10... - May 19, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Licenses Technology for the Treatment of Hyperhidrosis. - Mar 7, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com UREX Energy Corp. Upgraded to $3.00 per Share. - Nov 9, 2006 It offers OLUX Foam for the treatment of scalp dermatoses, and scalp and non-scalp psoriasis; Soriatane, an oral retinoid, to treat severe psoriasis in ... Free with registration - M2 Presswire - AccessMyLibrary.com Connetics Files Patent Infringement Lawsuit Against Agis, a Wholly- … - Oct 20, 2005 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... RedOrbit Connetics Names Shari Geffon Senior Director, Project Management; … - Jun 5, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to- … - Sep 19, 2006 The Company's commercial products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com New Rogaine(R) Foam Features Connetics' Proprietary VersaFoam(R) … - Sep 5, 2006 The Company's marketed products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Names Tim Pergram Regional Sales Director; Reports New … - May 30, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Reports Positive Results From Second Phase III Clinical... - Aug 28, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Isotretinoin registry: safety or regulation overkill?(News) - Oct 1, 2005 For example, we have a drug on the market, Soriatane (Connetics Corp.) that has a very long half-life, especially if someone were to take a drink of alcohol ... Free with registration - Dermatology Times - AccessMyLibrary.com Connetics Names Sunil Patel Vice President, Corporate Development … - May 8, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Genetic Engineering News - Genetic Engineering News (press release) Photo Quiz - September 15, 2006 -- American Family Physician - Sep 15, 2006 Systemic corticosteroids have been used to control occasional flares.2 Cyclosporine (Sandimmune), methotrexate, oral retinoids (eg, acitretin [Soriatane]), ... AAFP News Now Connetics Names Luis Pena Vice President, Project Management; … - Aug 22, 2005 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... RedOrbit Connetics Reports Preliminary Results for First Quarter 2006; Company... - May 3, 2006 Total revenues for the first quarter of 2006 were $47.7 million, including Soriatane(R) sales of $19.0 million, OLUX(R) sales of $14.1 million, ... Genetic Engineering News - Genetic Engineering News (press release) Connetics Names Cynthia Canup Director, Sales Training; Reports New … - Jun 1, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Genetic Engineering News - Genetic Engineering News (press release) Connetics Names Doris Boesch Director, Stability Programs; Reports … - Mar 24, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Names Liang Liu Associate Director, DMPK/Bioanalytical; … - Apr 24, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Q2 2006 Connetics Earnings Conference Call - Part 1. - Aug 15, 2006 Roughly 60% of that reduction went to Soriatane, about 25% to OLUX and the balance Luxiq. In the second quarter, the revenues benefited by about $2.9 ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Connetics Announces Results of Special Stockholders Meeting - Dec 20, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) ... Genetic Engineering News - Genetic Engineering News (press release) Isotretinoin (Systemic). - Feb 1, 2006 Acitretin (eg, Soriatane) or Tretinoin, oral (eg, Vesanoid) -- Use of isotretinoin with these medicines may result in an increase in side effects Hormonal ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Connetics Taps New M&A Pro.(appoints Sunil Patel) - May 22, 2006 Its products include scalp treatments Luxiq and Olux, an acne treatment called Evoclin and a psoriasis treatment called Soriatane. ... Free with registration - Mergers & Acquisitions Report - AccessMyLibrary.com Side Effects of Psoriasis Treatments - Dec 15, 2005 Systemic agents, which are taken in pill form, include the retinoid acritetin (Soriatane), methotrexate, cyclosporine and biologic agents. ... Health Video Connetics Announces 2005 Analyst and Investor Day in New York City; … - Mar 10, 2005 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |